3,4-Dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide
| Title | Journal |
|---|---|
| The antioxidant role of xanthurenic acid in the Aedes aegypti midgut during digestion of a blood meal. | PloS one 20120101 |
| Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. | Cell 20110610 |
| Inhibition of the kynurenine-NAD+ pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis. | Journal of neuropathology and experimental neurology 20101101 |
| Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides. | Neuropharmacology 20100101 |
| Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias. | Journal of molecular neuroscience : MN 20090601 |
| Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis. | Brain : a journal of neurology 20090501 |
| Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria. | International journal for parasitology 20090201 |
| Kynurenine pathway metabolites in humans: disease and healthy States. | International journal of tryptophan research : IJTR 20090101 |
| Effects of the kynurenine 3-hydroxylase inhibitor Ro 61-8048 after intrastriatal injections on the severity of dystonia in the dt sz mutant. | European journal of pharmacology 20080531 |
| Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys. | Behavioural brain research 20080125 |
| Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys. | Movement disorders : official journal of the Movement Disorder Society 20050701 |
| Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus. | Neuropharmacology 20050501 |
| The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia. | European journal of pharmacology 20030930 |
| Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. | Journal of neurochemistry 20020901 |
| Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. | Neuroscience 20010101 |